Source: International Congress 2019 – Asthma treatment: novel insights from clinical studies
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
T. Staton (South San Francisco, United States of America), S. Sukumaran (South San Francisco, United States of America), S. Rymut (South San Francisco, United States of America), G. Sperinde (South San Francisco, United States of America), M. Bremer (South San Francisco, United States of America), V. Steffen (South San Francisco, United States of America), P. Banerjee (South San Francisco, United States of America), F. Cai (South San Francisco, United States of America), J. Smith (South San Francisco, United States of America), H. Rhee (South San Francisco, United States of America), P. Belloni (South San Francisco, United States of America), J. Lin (South San Francisco, United States of America). Late Breaking Abstract - Dose-dependent inactivation of airway tryptase with a novel dissociating anti-Tryptase antibody (MTPS9579A) in healthy volunteers. 3707

Member's Comments

No comment yet.

Related content which might interest you: Late Breaking Abstract - CRAC channel inhibition by RP3128 triggers potent anti-inflammatory effects in COPD or asthmatic patient-derived primary cells Source: International Congress 2018 – New pharmacological strategies in airway diseases Year: 2018 Late Breaking Abstract - The first direct comparison between BAL-fluid and the PExA methodology in healthy individuals. Source: International Congress 2017 – Update and new perspectives in Airway Diseases Year: 2017 Late Breaking Abstract - Clinical utility of basophil activating test (BAT) in subjects with drug-induced lung disease. Source: International Congress 2018 – CTD-ILD and hypersensitivity pneumonitis: risk stratification and management Year: 2018 Late Breaking Abstract - Hypoxia-induced cellular responses in lung fibroblasts from COPD patients and controls Source: Virtual Congress 2021 – In vitro modelling of lung disease: reach out to the next dimension Year: 2021 Late Breaking Abstract - Elevated NETosis and migration but impaired anti-microbial responses by COVID-19 neutrophils Source: Virtual Congress 2021 – Acute COVID - 19 Year: 2021 Late Breaking Abstract - Anti-inflammatory and anti-fibrotic effect of novel, pan-PDE inhibitors in human bronchial epithelial cells Source: Virtual Congress 2020 – Scientific advances in airway pharmacology Year: 2020 Late Breaking Abstract - Preclinical study of anti-interleukin-4 alpha single domain antibody with therapeutic potential in asthma by oral inhalation Source: International Congress 2019 – Treatment of asthma with monoclonal antibodies Year: 2019 Late Breaking Abstract - Identification and functional testing of a novel receptor for SP-A on eosinophils Source: International Congress 2019 – Immunopathological mechanisms of lung disease Year: 2019 Late Breaking Abstract - Bronchial Thermoplasty restores constitutive high PRMT1 expression in asthmatic airways Source: International Congress 2017 – Notable abstracts in asthma Year: 2017 Enhanced inflammatory gene expression in bronchial epithelial cells from asthmatic patients: Attenuation by a Brd4 mimic Source: International Congress 2014 – Novel targets and drugs for asthma and COPD Year: 2014 Late Breaking Abstract - Comparison of clinical characteristics between severe adult asthmatics in Brazil(ProAR) and Europe(U-BIOPRED). Source: International Congress 2017 – Late-breaking findings in asthma and COPD Year: 2017 Late Breaking Abstract - Sex differences in ß2 adrenoceptor-mediated responses in mouse airways Source: International Congress 2019 – Advances in asthma pharmacology Year: 2019 Late Breaking Abstract -  Effect of Hypercapnia in human primary culture of alveolar cells in vitro Source: International Congress 2018 – Preclinical and clinical studies of critical illness Year: 2018 Late Breaking Abstract - Lack of stability of blood eosinophil counts in patients with COPD. Source: International Congress 2019 – Blood eosinophils and more in airway diseases Year: 2019 Late Breaking Abstract - Microbiome-driven clusters in severe asthma derived from induced sputum: identification and stability over time. Source: International Congress 2019 – Revealing novel asthma immunopathology endotypes Year: 2019 Late Breaking Abstract - Role of interleukin-10 in normal and aberrant late lung development Source: International Congress 2017 – Postnatal lung growth and development Year: 2017 Late Breaking Abstract - Transcriptional response to RSV in asthma primary bronchial epithelial cells: are the basal cells responsible for the reduced NF-kB response? Source: Virtual Congress 2021 – Mechanistic pathways in chronic and new lung diseases Year: 2021 Late Breaking Abstract - Roles for transglutaminases in normal and aberrant lung development associated with BPD. Source: International Congress 2017 – Late-breaking findings in pulmonary diseases Year: 2017 Late Breaking Abstract - Pharmacological characterization of T cell-induced broncho-constriction in vitro and in vivo Source: International Congress 2018 – Novel immunology-based therapies in asthma and COPD Year: 2018 Late Breaking Abstract - The inflammasome cluster is linked with airway NETosis in COPD Source: Virtual Congress 2021 – Cellular and molecular involvement in lung injury and repair Year: 2021